SCHEMBL2850801

SCHEMBL2850801

[Ru]=CSc1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4594015 0.97 MAPT (0.43)
SCHEMBL19305204 0.77 NPC1 (0.33)
SCHEMBL16862855 0.77 NPC1 (0.33)
SCHEMBL6959956 0.77
SCHEMBL9517370 0.75 ALDH1A1 (0.54)
SCHEMBL9517373 0.75 ALDH1A1 (0.54)
SCHEMBL8540596 0.75 MAPT (0.50)
SCHEMBL9517366 0.75 ALDH1A1 (0.54)
SCHEMBL6240262 0.71
SCHEMBL95991 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3087105-A1 METHOD FOR CONTROLLED METATHESIS DEPOLYMERIZATION OF SYNTHETIC RUBBER IN A SOLUTION Compagnie Générale des Etablissements Michelin (FR) 2016-11-02 EP disclosed
WO-2015097192-A1 METHOD FOR CONTROLLED METATHESIS DEPOLYMERIZATION OF SYNTHETIC RUBBER IN A SOLUTION COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2015-07-02 WO disclosed
WO-2010003658-A1 MACROCYCLIC INDOLE DERIVATIVES USEFUL AS HEPATITIS C VIRUS INHIBITORS TIBOTEC PHARMACEUTICALS (IE) 2010-01-14 WO disclosed